Jessica Harder, MD
Dr. Harder is a neuropsychiatrist with an interest in inflammation, autoimmune disorders, and neuropsychiatric disturbance. She obtained her medical degree from Weill Cornell Medical College, completed her residency in psychiatry at the Harvard Longwood training program, and her fellowship in Behavioral Neurology and Neuropsychiatry at Brigham and Women’s Hospital. She is the principal investigator on a randomized controlled trial of salicylic acid as an augmenting agent for treatment-resistant depression, as well as co-investigator on a trial of an IL-6 receptor antagonist for the treatment of depression. She is currently working with Dr. Joffe on a study of premenstrual inflammatory markers and their association with depression.
Fremonta Meyer, MD
Dr. Meyer is a consultation-liaison psychiatrist specializing in psycho-oncology, particularly women's cancers. Her current research focuses upon characterizing risk factors and interventions for fatigue, cognitive dysfunction, and depression in cancer patients. She is the principal investigator on a RCT assessing the effect of naltrexone on treatment-emergent fatigue during radiation therapy for breast cancer and is a co-investigator on Dr. Joffe's study assessing predictors of hot flashes on adjuvant endocrine therapy for breast cancer.
Leena Mittal, MD
Dr. Mittal is an Instructor in Psychiatry at Harvard Medical School and the Director of Reproductive Psychiatry Consultation in the Department of Psychiatry at BWH. She currently provides inpatient and outpatient psychiatry consultations at BWH. She obtained her medical degree from the University of Maryland School of Medicine, residency training in the Harvard Longwood Psychiatry Residency Training Program, and a fellowship in Psychosomatic Medicine at BWH. Her clinical interests include substance use and its treatment during pregnancy, as well as the mental health care of women with high risk pregnancy and with babies admitted to the neonatal intensive care unit. Dr. Mittal sees outpatients in a co-located clinic within the Maternal Fetal Medicine practice and is a consulting psychiatrist for McPAP for Moms.
Margo Nathan, MD
Dr. Nathan joined the Women’s Hormone and Aging Research Program in July 2016 as a clinical and research fellow and as junior faculty in July 2017. Prior to this she completed medical school at the University of Maryland School of Medicine and her adult Psychiatry Residency training at the Johns Hopkins Hospital. During her last year she served as chief resident. She has a particular interest in mood disorders and is hoping to pursue a career in academic psychiatry.
Jacob L. Taylor, MD, MPH
Dr. Taylor joined WHARP in July 2017 as a co-investigator on Dr. Joffe’s protocols investigating sleep disturbance during menopause. He completed his MD, MPH, and residency in psychiatry at Johns Hopkins University where he served as chief resident in his last year. He is currently a fellow working with the Broad Institute helping to develop tools for collecting phenotypic data in large-scale psychiatric genetic studies. He has a particular interest in mood disorders, substance-use disorders and non-substance related disorders of motivated behavior.
Women’s Hormones and Aging Research Program (WHARP) is a clinical and translational research group that aims to advance our understanding and treatment of symptoms resulting from estrogen withdrawal in the brain. This includes affective disturbance, sleep disruption, hot flashes, and cognitive performance. We study the biological basis of these symptoms as well as their interactions and strategies for optimizing treatment in healthy women during the menopause transition, women undergoing anti-estrogen therapy for breast cancer, and using experimental paradigms.